company background image
1SXP logo

SCHOTT Pharma KGaA XTRA:1SXP Stock Report

Last Price

€26.30

Market Cap

€4.0b

7D

-4.0%

1Y

n/a

Updated

23 Jun, 2024

Data

Company Financials +

SCHOTT Pharma AG & Co. KGaA

XTRA:1SXP Stock Report

Market Cap: €4.0b

1SXP Stock Overview

Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide.

1SXP fundamental analysis
Snowflake Score
Valuation5/6
Future Growth2/6
Past Performance6/6
Financial Health5/6
Dividends0/6

SCHOTT Pharma AG & Co. KGaA Competitors

Price History & Performance

Summary of all time highs, changes and price drops for SCHOTT Pharma KGaA
Historical stock prices
Current Share Price€26.30
52 Week High€43.40
52 Week Low€25.64
Beta0
11 Month Change-13.71%
3 Month Change-33.59%
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-15.97%

Recent News & Updates

We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt

Jun 07
We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt

Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Mar 28
Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Recent updates

We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt

Jun 07
We Think SCHOTT Pharma KGaA (ETR:1SXP) Can Stay On Top Of Its Debt

Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Mar 28
Calculating The Intrinsic Value Of SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)

Shareholder Returns

1SXPDE Life SciencesDE Market
7D-4.0%-3.9%0.09%
1Yn/a-15.6%3.1%

Return vs Industry: Insufficient data to determine how 1SXP performed against the German Life Sciences industry.

Return vs Market: Insufficient data to determine how 1SXP performed against the German Market.

Price Volatility

Is 1SXP's price volatile compared to industry and market?
1SXP volatility
1SXP Average Weekly Movement5.8%
Life Sciences Industry Average Movement6.0%
Market Average Movement4.9%
10% most volatile stocks in DE Market10.4%
10% least volatile stocks in DE Market2.6%

Stable Share Price: 1SXP's share price has been volatile over the past 3 months.

Volatility Over Time: 1SXP's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18844,687n/awww.schott-pharma.com

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold applications; SCHOTT TOPPAC sensitive, a polymer syringe for sensitive drugs; SCHOTT TOPPAC infuse, a polymer syringe for infusion therapy; and SCHOTT TOPPAC unique, a polymer container.

SCHOTT Pharma AG & Co. KGaA Fundamentals Summary

How do SCHOTT Pharma KGaA's earnings and revenue compare to its market cap?
1SXP fundamental statistics
Market cap€3.96b
Earnings (TTM)€158.11m
Revenue (TTM)€905.64m

25.1x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1SXP income statement (TTM)
Revenue€905.64m
Cost of Revenue€586.61m
Gross Profit€319.03m
Other Expenses€160.91m
Earnings€158.11m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Jun 27, 2024

Earnings per share (EPS)1.05
Gross Margin35.23%
Net Profit Margin17.46%
Debt/Equity Ratio15.6%

How did 1SXP perform over the long term?

See historical performance and comparison

Dividends

0.6%

Current Dividend Yield

14%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.